Post by Leonardo R◎ever MHS, PhD, Post-Doctorate, MBA(Data Science), Senior Scientific Editor

📢 🔎 🚨 Exercise-Based Cardiac Rehabilitation for Atrial Fibrillation: Meta-Analysis, Meta-Regression, and Trial Sequential Analysis ☑️ This article describes a contemporary review on the impact of exercise-based cardiac rehabilitation (ExCR) in patients with atrial fibrillation (AF). Below are the main topics of the text in the context of evidence-based healthcare: 1️⃣ Objective and Rigorous Methodology 🔖 Cochrane systematic review with meta-analysis, meta-regression, and trial sequential analysis (RTSA) to evaluate the impact of exercise-based cardiac rehabilitation (ExCR) in patients with atrial fibrillation (AF). 🔖 Inclusion of 20 randomized controlled trials (RCTs, n=2,039) with a mean follow-up of 11 months. 🔖 Assessment of bias (Cochrane Risk of Bias), quality of evidence (GRADE), and trial sequential analysis (RTSA). 2️⃣ Main Results ☑️ No impact on mortality or serious adverse events: ✔️ All-cause mortality: RR 1.06 (95% CI 0.76–1.48). ✔️ Serious adverse events: RR 1.30 (95% CI 0.66–2.56). ✅ Significant clinical benefits: 📛 Reduction in symptom severity (MD −1.61, 95% CI −3.06 to −0.16). 📛Decreased AF burden (MD −1.61, 95% CI −2.76 to −0.45). 📛Decreased frequency (MD −0.57) and duration of episodes (MD −0.58). 📛Reduced AF recurrence (RR 0.68, 95% CI 0.53–0.89). 📛Improved exercise capacity (peak VO₂ +3.18 mL/kg/min). 📛Improved mental quality of life, but not physical quality. 3️⃣ Comparison with Previous Evidence 📌 The 2017 Cochrane review had limited data, suggesting only modest improvements in exercise capacity. 📌This updated review (2024) confirms broader benefits, including symptom reduction and AF recurrence. 4️⃣ Implications for Clinical Practice and Policy ✅ ExCR should be considered in the management of AF, as it improves symptoms, functional capacity, and quality of life (mental aspect). ✅ No evidence of harm: Does not increase mortality or serious adverse events. ✅ Lack of current guidelines: ExCR is not yet widely recommended for AF, but this review supports its inclusion. 5️⃣ Limitations and Future Needs ✳️ Variable study quality: Some RCTs have a risk of bias and small sample sizes. ✳️ Need for further research: ✔️ Larger, more robust trials to confirm impact on mortality and safety. ✔️ Research on specific types of AF (paroxysmal vs. persistent) and optimal exercise protocols. 6️⃣ Conclusion for Evidence-Based Healthcare *️⃣ This review supports the use of ExCR in AF as a safe and beneficial intervention for symptoms and functional capacity, although it does not demonstrate an impact on mortality. 🔰 See the article: https://lnkd.in/dpbDtkhW 👉 Share and discuss. #AtrialFibrillation #CardiacRehabilitation